Clinical Microbiology


CHROMagar™ Candida Plus

Click on the picture for
Packaging / Colonies appearance

For detection and differentiation of major clinical Candida species, including C. auris

Typical Appearance of microorganisms

Candida albicans  green-blue
Candida auris  light blue with blue halo
Candida tropicalis  metallic blue with pink halo
Candida krusei → pink and fuzzy

Order References 

Please use these references when
contacting your local distributor:

5000 mL......... CA242
25 L............... CA243-25

Bulk on request

To download the certificate of analysis, please indicate your lot number below :


Medium Performance

1. High Specificity: Differentiation of the most common Candida species with very high specificity:
  • C. albicans ≈ 100 %*
  • C. tropicalis ≈ 100 %*
  • C. krusei ≈ 100 %*

2. Unique medium to differentiate C. auris from other Candida species: Owe to its high specificity, it can be used also as a screening tool in case of outbreaks.
  • Specificity ≈ 100 %*
  • Sensitivity ≈ 100 %*

* Specificity and Sensitivity from scientific study: «Evaluation of a novel chromogenic medium for Candida spp. identification and comparison with CHROMagarTM Candida for the detection of Candida auris in surveillance samples» Juan V. Mulet and al., 2020.

3. Easy identification: Identification by MALDI-TOF can be carried directly from a colony. No need of subculture.

Medium Description

Gain flexibility using powder rather than ready to use plates: Use the entire pack, or if there is a need for a smaller number of plates, just a portion. If kept under appropriate storage temperature, CHROMagarTM Candida Plus has a more than 12 months shelf life. This flexibility is essential to avoid the waste resulting from expired-unused plates.


Focus on Candida Species

The Candida are yeasts involved in various infections called Candidiasis, which can affect damaged skin, respiratory tract, digestive and urogenital systems. These Candidiasis can be severe with significant morbidity for nosocomial infections or in immunocompromised patients. Although C. albicans is still the main species involved, the use of anti fungal agents has even rise to other species such as C. tropicalis, C. krusei and C. glabrata.

In 2016, The World Health Organization added to this list, Candida auris, with a prevalence of over 90 % resistant to fluconazole. In addition, some strains are multi drug resistant to amphotericin B, voriconazole, and/or echinocandins.

It is recommended to carry out an early diagnosis of Candida in order to provide specific treatment as quickly as possible. Candida can be isolated by swabbing the skin, throat, rectum or urogenital tract.

CHROMagarTM Candida Plus is the first chromogenic isolation medium to detect and differentiate C. auris in addition to other major clinical Candida species such as C. albicans, C. tropicalis, C. glabrata or C. krusei.


Evaluation of a novel chromogenic medium for Candida spp. identification and comparison with CHROMagar Candida for the detection of Candida auris in surveillance samples


Juan V. Mulet Bayona, Carme Salvador Garcia, Nuria Tormo Palop, Concepcion Gimeno Cardona Diagnostic Microbiology & Infectious Disease August 2020

CHROMagar Candida Plus: A novel chromogenic agar that permits the rapid identification of Candida auris


Andrew M. Borma, Mark Fraser and Elizabeth M. Johnson ISHAM (International Society for Human and Animal Mycology) Medical Mycology, 2020, 0, 1-6

Candida auris in the UK: Introduction, dissemination, and control


Andrew M. Borman, Elizabeth M. Johnson University of Exeter, United Kingdom PLOS Pathogens July 30, 2020
more publications